United Orthopedic (4129) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 聯合

United Orthopedic (4129) reported revenue of NT$555.6 million for Oct 2026, +7.7% year on year and +17.7% from the previous month. Revenue for Jan–Oct 2026 was NT$5.14 billion (+10.4% year on year).

In Oct 2026, it ranked No. 15 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$460.3 million24/10Nov 2024 NT$440.6 millionDec 2024 NT$415 millionJan 2025 NT$396 millionFeb 2025 NT$416.3 million25/02Mar 2025 NT$484.9 millionApr 2025 NT$479.1 millionMay 2025 NT$418.7 millionJun 2025 NT$452.9 million25/06Jul 2025 NT$529.8 millionAug 2025 NT$452.9 millionSep 2025 NT$508.9 millionOct 2025 NT$515.8 million25/10Nov 2025 NT$500 millionDec 2025 NT$500.1 millionJan 2026 NT$475.5 millionFeb 2026 NT$446.3 million26/02Mar 2026 NT$572.6 millionApr 2026 NT$534.3 millionMay 2026 NT$500.6 millionJun 2026 NT$530.2 million26/06Jul 2026 NT$567.5 millionAug 2026 NT$486.8 millionSep 2026 NT$472.2 millionOct 2026 NT$555.6 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$555.6 million+7.7%+17.7%
Sep 2026NT$472.2 million-7.2%-3.0%
Aug 2026NT$486.8 million+7.5%-14.2%
Jul 2026NT$567.5 million+7.1%+7.0%
Jun 2026NT$530.2 million+17.1%+5.9%
May 2026NT$500.6 million+19.5%-6.3%
Apr 2026NT$534.3 million+11.5%-6.7%
Mar 2026NT$572.6 million+18.1%+28.3%
Feb 2026NT$446.3 million+7.2%-6.1%
Jan 2026NT$475.5 million+20.1%-4.9%
Dec 2025NT$500.1 million+20.5%+0.0%
Nov 2025NT$500 million+13.5%-3.1%
Oct 2025NT$515.8 million+12.1%+1.4%
Sep 2025NT$508.9 million+30.2%+12.4%
Aug 2025NT$452.9 million+40.1%-14.5%
Jul 2025NT$529.8 million+27.2%+17.0%
Jun 2025NT$452.9 million+22.6%+8.1%
May 2025NT$418.7 million+6.3%-12.6%
Apr 2025NT$479.1 million+27.0%-1.2%
Mar 2025NT$484.9 million+22.0%+16.5%
Feb 2025NT$416.3 million+40.4%+5.1%
Jan 2025NT$396 million+6.5%-4.6%
Dec 2024NT$415 million+19.8%-5.8%
Nov 2024NT$440.6 million+15.7%-4.3%
Oct 2024NT$460.3 million+13.1%+17.8%

Jan–Oct 2026 cumulative: NT$5.14 billion (+10.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: United Orthopedic vs PEC / United Orthopedic vs Lotus Pharm / United Orthopedic vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16